AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Triblend VG1 Tablet SR

Prescription Icon
Prescription Required

Marketer

Akesiss Pharma Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Triblend VG1 Tablet SR

Combiflex DM SR tablets are classified as antidiabetic medications. This combination therapy is indicated for adult patients with type 2 diabetes mellitus to manage blood glucose levels. Always take Combiflex DM SR with food, consistently at the same time daily for optimal effectiveness. Dosage will be determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with well-controlled blood sugar, as discontinuation without medical consultation can lead to elevated blood glucose, increasing the risk of complications like kidney disease, vision impairment, neuropathy, and limb loss. Remember, this medication is just one component of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are vital for diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect. Learn to recognize symptoms such as sweating, dizziness, headache, and tremors, and know how to address them promptly. Maintain regular mealtimes and carry readily available glucose sources like sugary snacks or juice. Alcohol consumption should be minimized due to its potential to worsen hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your doctor before commencing treatment. Pregnant or breastfeeding individuals require medical consultation before use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to track blood cell counts and liver function.

Uses of Triblend VG1 Tablet SR

Managing Type 2 Diabetes

Major Benefits of Triblend VG1 Tablet SR:

Administer this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment schedule. Ingest the Triblend VG1 Tablet SR whole; avoid chewing, crushing, or fracturing it. Consume it on an empty stomach.

Common Side effects of Triblend VG1 Tablet SR:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Triblend VG1 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Triblend VG1 Tablet SR. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Administer this medication on an empty stomach.

How Triblend VG1 Tablet SR works:

Extended-release Triblend VG1 tablets contain a triple-drug formulation for diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Triblend VG1 Tablet SR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Triblend VG1 Tablet SR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Triblend VG1 Tablet SR while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

Patients with kidney impairment should likely avoid Triblend VG1 Tablet SR, as its use may be unsafe. A physician's consultation is advised. Furthermore, this medication is unsuitable for individuals with severely compromised kidney function.

LiverLiverCAUTION

Patients with liver impairment should use Triblend VG1 Tablet SR cautiously, potentially requiring dosage modification. Consult a physician for guidance. Low initial doses are typically prescribed for those with mild to moderate hepatic dysfunction; the medication is contraindicated in individuals with severe liver disease.

What if you forget to take Triblend VG1 Tablet SR :

Should you forget to take a Triblend VG1 Tablet SR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Triblend VG1 Tablet SR

LabelValue
Addictive None.
Medication Classification Medication for diabetes

FAQs on Triblend VG1 Tablet SR

Triblend VG1 SR tablets contain glimepiride, metformin, and voglibose, a triple-drug formulation for managing type 2 diabetes mellitus in adults. This medication helps regulate blood sugar when combined with a healthy diet and regular physical activity. Glimepiride stimulates pancreatic insulin secretion, reducing blood glucose. Metformin decreases hepatic glucose production and enhances insulin responsiveness. Voglibose, an alpha-glucosidase inhibitor, reduces post-meal glucose levels. This combination therapy is unsuitable for type 1 diabetes.
Taking Triblend VG1 Tablet SR may cause common side effects including low blood sugar, nausea, diarrhea, changes in taste perception, gas, abdominal pain, headache, skin rash, and respiratory illness.
Triblend VG1 Tablet SR is contraindicated in individuals with hypersensitivity to its constituents or inactive ingredients. This medication should also not be administered to patients exhibiting moderate to severe renal impairment, inflammatory bowel disorders, colonic ulcers, or underlying metabolic acidosis, such as diabetic ketoacidosis.
Consuming alcohol concurrently with Triblend VG1 Tablet SR is inadvisable. This combination may lead to dangerously low blood glucose and heighten the risk of lactic acidosis.
Triblend VG1 Tablet SR can indeed lead to hypoglycemia, characterized by low blood sugar. This manifests as nausea, headache, irritability, hunger pangs, sweating, dizziness, rapid heartbeat, and feelings of anxiety or tremors. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is advisable.
Retain this medication within its original, sealed packaging. Follow the storage directions printed on the packaging or label. Discard any leftover medication. Prevent access by children, pets, and others.
Triblend VG1 Tablet SR
107
MRP 130
17% off